Cargando…

Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States

BACKGROUND: The literature on the cost-effectiveness of statin drugs in primary prevention of coronary heart disease is complex. The objective of this study is to compare the disparate results of recent cost-effectiveness analyses of statins. FINDINGS: We conducted a systematic review of the literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Aaron P, Simpson, Ross J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444438/ https://www.ncbi.nlm.nih.gov/pubmed/22828389 http://dx.doi.org/10.1186/1756-0500-5-373

Ejemplares similares

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
por: Armstrong, Shannon O, et al.
Publicado: (2019)

Determinants of the Cost-Effectiveness of Statins
por: Morrison, Alan, et al.
Publicado: (2003)

Evaluating the Cost-Effectiveness of Statins
por: Hay, Joel W.
Publicado: (2004)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
por: Kim, Kyu, et al.
Publicado: (2020)

Incidence and costs of injuries to children and adults in the United States
por: Zonfrillo, Mark R., et al.
Publicado: (2018)

When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
por: Catalá-López, Ferrán, et al.
Publicado: (2013)

Challenges in Evaluating the Cost-Effectiveness of Statins
por: Ohsfeldt, Robert L.
Publicado: (2004)

Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
por: Kohli-Lynch, Ciaran N., et al.
Publicado: (2022)

The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients with Cardiovascular Disease, A Systematic Review
por: Eisavi, Mahmoud, et al.
Publicado: (2021)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
por: Shah, Aditya, et al.
Publicado: (2022)

Time and cost of administering COVID-19 mRNA vaccines in the United States
por: Yarnoff, Benjamin, et al.
Publicado: (2021)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review
por: Bozzani, Fiammetta M., et al.
Publicado: (2022)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
por: Wang, Miao, et al.
Publicado: (2020)

Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price
por: Sinha, Pranay, et al.
Publicado: (2022)

Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities
por: McManus, Kathleen A., et al.
Publicado: (2022)

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
por: Sasidharan, Akhil, et al.
Publicado: (2022)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Chen, Jieling, et al.
Publicado: (2014)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review
por: Conteh, Lesong, et al.
Publicado: (2021)

Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review
por: Bosetti, Rita, et al.
Publicado: (2021)

The Cost of Hyperkalemia in the United States
por: Betts, Keith A., et al.
Publicado: (2017)

Primary prevention programs for childhood obesity: are they cost-effective?
por: Guarino, Miriana, et al.
Publicado: (2023)

Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2019)

Surgical revascularization for Moyamoya disease in the United States: A cost-effectiveness analysis
por: Wali, Arvin R., et al.
Publicado: (2021)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States
por: Shrestha, Ram K., et al.
Publicado: (2023)

Cost-Effectiveness of High, Moderate and Low-Dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System
por: Ribeiro, Rodrigo Antonini, et al.
Publicado: (2015)

HIV prevention cost-effectiveness: a systematic review
por: Galárraga, Omar, et al.
Publicado: (2009)

Cost, health impacts and cost effectiveness of iceless refrigeration in India's last-mile vaccine cold chain delivery
por: Plewes, Katherine, et al.
Publicado: (2022)

Recent Trends in Hypoparathyroidism-Related Inpatient and Emergency Department Admissions and Costs in the United States
por: Kaul, Sanjiv, et al.
Publicado: (2023)

Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States
por: Lee, Min Jee, et al.
Publicado: (2018)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
por: Jahangiri, Reza, et al.
Publicado: (2022)

Cardiovascular disease preventive effects of aspirin combined with different statins in the United States general population
por: Liu, Tao, et al.
Publicado: (2023)

Cost of illness of hyponatremia in the United States
por: Boscoe, Audra, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_flphn80miaoujcfffog4tdaquv